Global CBD and CBG Biomass Market Trends Analysis By Source (Hemp biomass, Cannabis biomass), By Extraction Method (CO2 extraction, Solvent-based extraction), By Application (Pharmaceuticals, Nutraceuticals & Dietary Supplements), By Regions and Forecast

CBD and CBG Biomass Market Size and Forecast 2026-2033

CBD and CBG Biomass Market size was valued at USD 6.8 Billion in 2024 and is projected to reach USD 22.5 Billion by 2033, growing at a CAGR of 14.2% from 2026 to 2033. The market expansion is underpinned by rising global demand for cannabinoid-based formulations across pharmaceutical and wellness industries. Increasing cultivation acreage and advancements in biomass processing technologies are further accelerating supply chain efficiency. Strong consumer adoption in regulated markets is expected to sustain long-term revenue growth.

What are CBD and CBG Biomass Market?

The CBD and CBG biomass market refers to the cultivation, harvesting, processing, and commercialization of hemp-derived plant material rich in cannabidiol and cannabigerol compounds. Biomass typically includes dried flowers, leaves, and stalks used as raw input for cannabinoid extraction and formulation. This market forms the upstream foundation of the broader cannabinoid value chain, supporting pharmaceutical-grade isolates, full-spectrum extracts, and consumer wellness products. Strategic relevance lies in its role in ensuring cost-efficient, scalable, and quality-controlled supply for downstream industries. Increasing standardization and regulatory compliance frameworks are shaping the evolution of this market into a structured agro-industrial segment.

Key Market Trends

The CBD and CBG biomass market is undergoing structural transformation driven by industrial-scale cultivation, vertical integration, and product diversification. Market participants are focusing on supply chain optimization and precision agriculture to enhance yield quality and cannabinoid concentration. Consumer behaviour trends are shifting toward natural therapeutics and plant-based wellness products, increasing biomass demand globally. Digital transformation in farm management and traceability systems is improving transparency and compliance. Sustainability mandates are encouraging eco-friendly cultivation practices, further shaping industry-specific innovations and competitive landscape dynamics.

• Expansion of industrial hemp cultivation has increased global biomass output by over 25% between 2021 and 2024, improving economies of scale.
• CBG-focused biomass cultivation is rising, with CBG acreage growing at over 30% annually due to its emerging therapeutic applications.
• Adoption of precision farming technologies has improved cannabinoid yield efficiency by nearly 18%, enhancing profitability for growers.
• Demand for organic and pesticide-free biomass is increasing, with premium pricing reaching 20–30% above conventional biomass in regulated markets.
• Vertical integration strategies among producers and extractors are reducing operational costs by approximately 15% across the value chain.
• Advancements in post-harvest processing, including cryogenic drying and biomass preservation, are improving cannabinoid retention rates by up to 22%.

Key Market Drivers

The growth of the CBD and CBG biomass market is primarily driven by the increasing acceptance of cannabinoid-based products across healthcare, nutraceutical, and personal care sectors. Expanding legalization frameworks across North America, Europe, and parts of Asia-Pacific are enabling commercial-scale production and distribution. Rising prevalence of chronic conditions and growing demand for alternative therapies are fueling product adoption. Improved agricultural practices and genetics are enhancing biomass productivity. Furthermore, evolving go-to-market strategies and retail expansion are strengthening demand visibility across both B2B and B2C channels.

• Global legalization trends have enabled over 50 countries to permit hemp cultivation, expanding the addressable biomass market significantly.
• Chronic pain affects over 20% of the global population, increasing demand for cannabinoid-based therapeutic solutions.
• Consumer spending on plant-based wellness products has grown by over 12% annually, directly boosting biomass demand.
• Advancements in hemp genetics have increased CBD yield per acre by nearly 35% over the past five years.
• Healthcare expenditure globally has surpassed USD 9 trillion, supporting integration of alternative treatments including cannabinoids.
• Rising e-commerce penetration, with over 65% of CBD product sales occurring online in key markets, is enhancing distribution efficiency.

Key Market Restraints

The CBD and CBG biomass market faces several structural and regulatory challenges. Inconsistent global regulatory frameworks create uncertainty in cultivation, processing, and cross-border trade. Price volatility due to oversupply in certain regions has impacted farmer profitability. Quality standardization and testing requirements remain complex, particularly for export-oriented producers. Limited awareness and stigma in certain regions continue to restrict adoption. Supply chain inefficiencies and lack of infrastructure in emerging markets further constrain scalability and market penetration strategies.

• Regulatory fragmentation across regions leads to compliance costs increasing by up to 20% for exporters.
• Biomass price fluctuations have seen declines of over 40% during periods of oversupply, affecting producer margins.
• Strict THC content limits, often below 0.3%, restrict cultivation flexibility and increase crop failure risks.
• Testing and certification costs can account for 8 to 12% of total production expenses, impacting profitability.
• Limited processing infrastructure in developing regions reduces biomass utilization efficiency by up to 30%.
• Banking and financial restrictions in certain markets limit capital access for small and mid-scale producers.

Key Market Opportunities

The CBD and CBG biomass market presents significant growth opportunities driven by evolving regulatory clarity, technological advancements, and diversification of applications. Emerging markets in Asia-Pacific, Latin America, and Africa are opening new cultivation zones with favorable climatic conditions. Innovations in cannabinoid extraction and formulation are expanding the commercial value of biomass. Strategic partnerships and contract farming models are enhancing supply chain resilience. Increasing investment in research and development is unlocking new therapeutic uses, positioning the market for long-term expansion.

• Untapped cultivation potential in emerging economies could increase global biomass supply by over 40% in the next decade.
• Development of high-CBG hemp strains is expected to unlock a niche market growing at over 20% CAGR.
• Pharmaceutical-grade cannabinoid applications are projected to account for over 35% of biomass demand by 2030.
• Adoption of blockchain-based traceability systems is improving supply chain transparency and reducing fraud risks.
• Contract farming models are enabling small-scale farmers to increase income by up to 25% through assured procurement.
• Expansion into functional foods and beverages is creating new revenue streams, with projected market growth exceeding USD 5 billion by 2030.

CBD and CBG Biomass Market Applications and Future Scope

The future trajectory of the CBD and CBG biomass market is defined by its integration across multiple high-growth industries and its evolution into a technologically advanced agricultural segment. In pharmaceuticals, biomass will increasingly support the development of standardized cannabinoid-based drugs targeting neurological disorders, pain management, and inflammation. Nutraceutical and dietary supplement applications will expand as consumers prioritize preventive healthcare and natural remedies. Cosmetics and personal care sectors will leverage antioxidant and anti-inflammatory properties for premium skincare formulations. Functional food and beverage applications will continue to scale, supported by innovation in infusion technologies and regulatory approvals.

Industrial applications, including bio-based materials and sustainable textiles derived from hemp biomass, are expected to gain traction under global sustainability mandates. The convergence of biotechnology and precision agriculture will enable genetically optimized crops with higher cannabinoid yields and climate resilience. Digital transformation will further streamline cultivation monitoring, supply chain traceability, and quality assurance. As regulatory frameworks mature and global acceptance increases, the CBD and CBG biomass market is poised to become a cornerstone of the broader bioeconomy, offering diversified revenue streams and long-term value creation for stakeholders.

CBD and CBG Biomass Market Scope Table

CBD and CBG Biomass Market Segmentation Analysis

By Source

• Hemp biomass
• Cannabis biomass
• Hybrid strains

The source-based landscape of this industry is strongly led by hemp-derived raw material, accounting for over 62% of global volume share in 2025, driven by its legal acceptance across North America and Europe, lower THC concentration, and cost-efficient large-scale cultivation. Average biomass yield from hemp farms has reached 2.5–3.2 tons per acre, supporting high extraction throughput and stable supply chains for cannabidiol and cannabigerol production. Cannabis-derived input holds nearly 25% share, benefiting from higher cannabinoid potency levels, often exceeding 12–18% CBD concentration, making it attractive for premium therapeutic formulations despite regulatory constraints and higher cultivation costs. Hybrid genetic variants are gaining traction with a projected CAGR above 18%, as breeders focus on optimizing cannabinoid profiles, increasing CBG yield beyond 5%, and improving resistance to climate variability. This shift is opening opportunities in precision agriculture, indoor cultivation technologies, and genetically stabilized strains, enhancing scalability and extraction efficiency across emerging markets.

By Extraction Method

• CO2 extraction
• Solvent-based extraction
• Steam distillation

The processing approach using supercritical carbon dioxide leads the CBD and CBG biomass market, accounting for nearly 48% of global revenue share in 2025 due to its high purity output, minimal residual contamination, and scalability for pharmaceutical and nutraceutical applications. This method is widely adopted in North America and Europe, where over 60% of licensed processors favor it for premium-grade cannabinoid production, supporting margins that are 20% higher than conventional techniques. Hydrocarbon and ethanol-based processing collectively represent around 37% of market share, driven by lower capital expenditure and faster throughput, particularly in large-scale industrial facilities across Asia-Pacific and Latin America, where cost efficiency remains critical. Ethanol extraction alone has witnessed a 12% annual adoption growth, supported by improvements in solvent recovery systems and winterization efficiency. Steam-based techniques hold a smaller share of approximately 15%, primarily used in niche applications focused on terpene preservation and organic labeling, with rising demand in cosmetics and wellness segments. Increasing investment in hybrid extraction technologies and automation is expected to unlock new opportunities, especially in emerging markets prioritizing yield optimization and regulatory compliance.

By Application

• Pharmaceuticals
• Nutraceuticals & Dietary Supplements
• Cosmetics & Personal Care
• Food & Beverages

The demand landscape across end-use industries is led by healthcare-oriented formulations, where therapeutic formulations account for over 38% of total consumption due to increasing clinical validation of cannabinoid-based therapies for pain management, epilepsy, and anxiety disorders. Strong regulatory progression in North America and parts of Europe continues to accelerate adoption, with prescription-based formulations witnessing double-digit annual growth above 12%. Wellness-focused ingestibles hold nearly 27% share, supported by rising consumer inclination toward plant-derived functional nutrition, particularly in capsules, tinctures, and powders. Personal care applications are gaining rapid traction, expanding at a CAGR exceeding 14%, driven by anti-inflammatory and anti-aging product innovations, especially in premium skincare lines. Edible formats contribute around 18% of revenue, benefiting from legalization trends and expanding retail penetration, with beverages emerging as a high-growth niche due to microdosing innovations. Future opportunities lie in fortified functional foods, sports recovery products, and hybrid botanical formulations combining minor cannabinoids for enhanced efficacy.

CBD and CBG Biomass Market Regions

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Netherlands
• Asia-Pacific
  • China
  • Australia
  • Japan
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Israel

CBD and CBG Biomass Market Key Players

• Canopy Growth Corporation
• Aurora Cannabis Inc.
• Tilray Brands Inc.
• Cronos Group
• GW Pharmaceuticals
• Folium Biosciences
• Charlotte's Web Holdings Inc.
• CV Sciences Inc.
• Medical Marijuana Inc.
• Elixinol Global Limited
• GenCanna Global
• Hemptown USA
• Kazmira LLC
• Pharmahemp
• CBD American Shaman
• Endoca
• Green Roads
  NuLeaf Naturals

Research Methodology of Market Trends Analysis

Executive Objective

• The primary objective of this study is to provide a comprehensive quantitative and qualitative assessment of the global CBD and CBG biomass market, identifying high-growth cultivation regions and extraction-ready feedstock availability.
• This research aims to evaluate the shifting supply-side dynamics as the industry transitions from a CBD-dominant landscape to a multi-cannabinoid market with increasing demand for Cannabigerol (CBG).
• The study was conducted to assist stakeholders in understanding price volatility, the impact of genetic innovation on cannabinoid yields, and the alignment of biomass production with pharmaceutical and nutraceutical purity standards.

Primary Research Details

• Interviews with Industry Experts: In-depth consultations were held with C-suite executives, master growers, and extraction facility managers to gain insights into harvest cycles, terpene preservation, and post-harvest processing costs.
• Supply Chain Mapping: Direct communication with large-scale industrial hemp farmers and cooperative aggregators was used to verify acreage, yield per acre, and the percentage of biomass meeting "medical-grade" specifications.
• Demand-Side Surveying: Data was gathered from wholesale purchasers and laboratory procurement officers to determine preferred moisture content levels and maximum allowable limits for heavy metals and pesticides.
• Field Observations: Technical assessments were performed regarding the adoption of mechanized harvesting versus hand-shucking and its subsequent impact on biomass quality and cannabinoid degradation.

Secondary Research Sources

• Regulatory & Governmental Databases: Information was extracted from the U.S. Department of Agriculture (USDA) Hemp Program records, the European Industrial Hemp Association (EIHA), and Health Canada’s licensing data.
• Scientific & Academic Literature: Peer-reviewed studies from MDPI, ScienceDirect, and the Journal of Industrial Hemp provided technical benchmarks for cannabinoid synthesis and soil remediation impacts.
• Financial & Trade Portals: Analysis of import/export manifests through Panjiva and ImportGenius, alongside commodities pricing from the Hemp Benchmarks spot price index.

Assumptions & Limitations

• Regulatory Stability: The market forecast assumes a stable global regulatory environment, specifically maintaining the current 0.3% THC threshold in the U.S. and 0.3% in the EU, without sudden prohibitive shifts in "Novel Food" status.
• Geopolitical Climate: It is assumed that no major global trade wars or catastrophic supply chain disruptions occur that would impede the international movement of hemp seeds or bulk biomass.
• Standardized Testing: Forecasts rely on the assumption that laboratory testing protocols will become more harmonized, reducing the current discrepancies in "Certificate of Analysis" (COA) reporting across different jurisdictions.
• Genetic Consistency: The study assumes that hemp genetics will continue to stabilize, minimizing the risk of "hot" crops (exceeding THC limits) which can lead to significant biomass destruction and market supply shocks.